|
Dan Kuritzkes, MD |
![]() |
Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics
and Biochemistry from Yale University in 1978, and his MD from Harvard Medical
School in 1983. He completed his clinical and research training in internal
medicine and infectious disease at Massachusetts General Hospital, and was a
visiting scientist at the Whitehead Institute for Biomedical Research before
joining the faculty at the University of Colorado Health Sciences Center in
1990. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is
Professor of Medicine and Director of AIDS Research, Brigham & Women's Hospital.
He is also Head of the Section of Retroviral Therapeutics for the Harvard
Division of AIDS, and Principal Investigator of the Harvard AIDS Clinical Trials
Unit.
Dr. Kuritzkes has authored nearly 200 articles, chapters, and reviews on
antiretroviral therapy and on the problem of drug resistance in HIV-1 infection.
He has chaired several multicenter studies of HIV therapy and is a member of the
International AIDS Society-USA panel on HIV drug resistance and resistance
testing. He has served on numerous NIH committees and editorial boards, and
currently chairs the AIDS Clinical Trials Group Scientific Agenda Steering
Committee, in addition to serving as Vice Chair of the ACTG Executive Committee.
Dr. Kuritzkes also is an Associate Editor of the Journal of Infectious Diseases
and Chair, Board of Directors of the HIV Medicine Association. His research
interests focus on antiretroviral therapy and drug resistance.